These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 18929839)
41. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate. Hou G; Dick R; Brewer GJ Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. Sonoyama T; Tamura N; Miyashita K; Park K; Oyamada N; Taura D; Inuzuka M; Fukunaga Y; Sone M; Nakao K FEBS Lett; 2009 Jun; 583(12):2067-70. PubMed ID: 19463821 [TBL] [Abstract][Full Text] [Related]
43. Pentoxifylline prevents pig serum-induced rat liver fibrosis by inhibiting interleukin-6 production. Toda K; Kumagai N; Kaneko F; Tsunematsu S; Tsuchimoto K; Saito H; Hibi T J Gastroenterol Hepatol; 2009 May; 24(5):860-5. PubMed ID: 19220679 [TBL] [Abstract][Full Text] [Related]
44. A liver DNA synthesis promoter induced in rat plasma by injection of dimethylnitrosamine (DMNA) or thioacetamide. Díaz-Gil JJ; Sánchez G; Santamaría L; Trilla C; Esteban P; Escartín P; Gea T Br J Cancer; 1987 Jun; 55(6):599-604. PubMed ID: 3620300 [TBL] [Abstract][Full Text] [Related]
45. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
46. Novel liver fibrosis model in Macaca fascicularis induced by thioacetamide. Matsuo M; Murata S; Hasegawa S; Hatada Y; Ohtsuka M; Taniguchi H Sci Rep; 2020 Feb; 10(1):2450. PubMed ID: 32051422 [TBL] [Abstract][Full Text] [Related]
47. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365 [TBL] [Abstract][Full Text] [Related]
48. Copper-associated liver disease in North Ronaldsay sheep: a possible animal model for non-Wilsonian hepatic copper toxicosis of infancy and childhood. Haywood S; Müller T; Müller W; Heinz-Erian P; Tanner MS; Ross G J Pathol; 2001 Sep; 195(2):264-9. PubMed ID: 11592108 [TBL] [Abstract][Full Text] [Related]
49. Early urinary candidate biomarker discovery in a rat thioacetamide-induced liver fibrosis model. Zhang F; Ni Y; Yuan Y; Yin W; Gao Y Sci China Life Sci; 2018 Nov; 61(11):1369-1381. PubMed ID: 29961236 [TBL] [Abstract][Full Text] [Related]
50. [Chronic thioacetamide poisoning as a model for experimental liver cirrhosis]. Grasedyck K; Lindner J Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():374-6. PubMed ID: 1029213 [No Abstract] [Full Text] [Related]
51. Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents. Landon EJ; Naukam RJ; Rama Sastry BV Biochem Pharmacol; 1986 Feb; 35(4):697-705. PubMed ID: 3947399 [TBL] [Abstract][Full Text] [Related]
53. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. Park JH; Jo JH; Kim KH; Kim SJ; Lee WR; Park KK; Park JB J Gene Med; 2009 Sep; 11(9):824-33. PubMed ID: 19554625 [TBL] [Abstract][Full Text] [Related]
54. Continuos intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat. Ishigaki N; Yamamoto N; Jin H; Uchida K; Terai S; Sakaida I Biochem Biophys Res Commun; 2009 Jan; 378(3):354-9. PubMed ID: 18996092 [TBL] [Abstract][Full Text] [Related]
55. Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease. Madden JW; Gertman PM; Peacock EE Surgery; 1970 Jul; 68(1):260-7; discussion 267-8. PubMed ID: 10483478 [TBL] [Abstract][Full Text] [Related]
57. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008 [TBL] [Abstract][Full Text] [Related]
58. Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model. Chiu V; Yee C; Main N; Stevanovski I; Watt M; Wilson T; Angus P; Roberts T; Shackel N; Herath C Clin Sci (Lond); 2024 Oct; 138(19):1227-1248. PubMed ID: 39254423 [TBL] [Abstract][Full Text] [Related]
59. Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Loebermann M; Sombetzki M; Langner C; Fuchsbichler A; Gumhold J; Silbert D; Riebold D; Holtfreter M; Fickert P; Nizze H; Trauner M; Reisinger EC Trop Med Int Health; 2009 Nov; 14(11):1418-25. PubMed ID: 19747186 [TBL] [Abstract][Full Text] [Related]
60. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats. Lai JT; Hsieh WT; Fang HL; Lin WC Clin Nutr; 2009 Jun; 28(3):338-45. PubMed ID: 19233522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]